FDA Announces The Discontinuation Of Certain COVID-19-Related Guidance Documents - Operational Impacts and Strategy

In the wake of the Department of Health and Human Services' (HHS) February announcement that they will be discontinuing the COVID-19 public health emergency (PHE) declaration on May 11, 2023...

Related Keywords

United States , ,Coagulation Systems For Measurement Of Viscoelastic Properties ,Health Care ,Guidance Documents Expiring With The Public Health ,Expiration Of The Public Health Emergency ,Development Of Monoclonal Antibody Products ,Health Emergency ,Public Health Emergency ,Public Health Emergency Guidance ,Enforcement Policy For Digital Health Devices ,Human Services ,Development Of Abbreviated New Drug Applications During ,Drug Administration ,Party Certification ,Public Health Emergency Guidance For Industry ,Public Health ,Animal Drug Development ,Department Of Health ,Health Emergency Guidance For Industry ,Public Health Emergency On ,Program Onsite Observation ,United States Food ,Federal Register ,Resuming Normal Drug ,Manufacturing Operations During ,Health Emergency Guidance ,Digital Health Devices ,Treating Psychiatric Disorders During ,Coronavirus Disease ,Non Invasive Fetal ,Maternal Monitoring Devices Used ,Support Patient Monitoring ,Use Authorization ,Monoclonal Antibody Products ,Including Addressing ,Non Invasive Remote ,Monitoring Devices Used ,Support Patient Monitoring During ,Postmarketing Adverse Event Reporting ,Medical Products ,Dietary Supplements During ,Documents Subject ,Documents Expiring With ,Gene Therapy Products During ,Health Emergency Policy ,Mitigating Nonhuman Primate ,Supply Constraints Arising ,Abbreviated New Drug Applications During ,Bioequivalence Studies ,Applicant Responses ,Complete Response ,Letters When ,Facility Assessment ,Needed During ,Normal Drug ,Biologics Manufacturing Operations ,Manufacturing Practice Considerations ,Biological Products ,Clinical Trials During ,User Fee Applications ,Certain Drugs ,Hospitalized Patients ,Outsourcing Facilities During ,Pharmacy Compounders ,Sterile Compounding ,Prescription Drug Marketing Act Requirements ,Drug Samples During ,General Considerations ,Certain Requirements ,Supply Chain Security Act During ,Permanent Discontinuance ,Device Under Section ,Quality Standards ,Quality Standards Act During ,Policy Regarding Enforcement ,Egg Safety Rule ,Policy Regarding Packaging ,Shell Eggs ,Retail Food Establishments During ,Policy Regarding Nutrition Labeling ,Packaged Food During ,Temporary Closure ,Significantly Reduced ,Human Food Establishment ,Assistance During ,Documents Discontinuing ,Temporary Use ,Portable Cryogenic Containers ,Compliance With ,Supply Chain ,Biological Product ,Inspections During ,Health Emergency Questions ,Standard Menu ,Chain Restaurants ,Similar Retail Food Establishments ,Minor Formulation ,Policy During ,Qualified Exemption ,Support New Animal Drug Development ,Policy Guidance Documents Continuing ,Longer After ,Remote Digital Pathology Devices During ,Imaging Systems During ,Telethermographic Systems During ,Psychiatric Disorders During ,Extracorporeal Membrane Oxygenation ,Cardiopulmonary Bypass Devices During ,Remote Ophthalmic Assessment ,Monitoring Devices During ,Infusion Pumps ,Accessories During ,Face Shields ,Surgical Masks ,Respirators During ,Gloves During ,Disinfectant Devices ,Air Purifiers During ,Respiratory Devices During ,Viscoelastic Properties ,Enforcement Policy During ,Viral Transport Media During ,Revise Within ,Immunodeficiency Virus Transmission ,Blood Components During ,Clinical Trials ,Developing Drugs ,Isopropyl Alcohol ,Including During ,Potency Assay Considerations ,Monoclonal Antibodies ,Related Symptoms ,Outpatient Adult ,Adolescent Subjects ,Review Board ,Individual Patient ,Expanded Access Requests ,Investigational Drugs ,Products During ,Manufacturing Under Section ,Fact Guidance ,Master Protocols Evaluating Drugs ,Interactive Evaluations ,Drug Manufacturing ,Bioresearch Monitoring Facilities During ,Emergency Guidance ,Closure System ,Component Changes ,Stoppers Guidance ,Monoclonal Antibody Products Targeting ,Face Masks ,Barrier Face Coverings ,Approved Premarket Approval ,Humanitarian Device Exemption ,Submissions During ,Clinical Electronic Thermometers During ,Non Invasive Remote Monitoring Devices ,Refrigerated Transport Vehicles ,Storage Units ,Food Uses After Using Them ,Preserve Human ,Remains During ,Policy Regarding Preventive Controls ,Certificate Duration Requirements ,Mitigating Animal Drug Shortages ,Documents That Will Remain ,Post Public Health ,Specific Guidances ,Adverse Event Reporting ,Evaluating Impact ,Viral Mutations ,Mondaq ,Fda Announces The Discontinuation Of Certain Covid 19 Related Guidance Documents ,Coronavirus Covid 19 ,Government Measures ,Operational Impacts And Strategy ,Food ,Drugs ,Healthcare ,Life Sciences ,Food And Drugs Law ,Iotechnology Amp Nanotechnology ,